Your browser doesn't support javascript.
Euglycemic DKA (euDKA) as a presentation of COVID-19.
Dass, Bhagwan; Beck, Andrew; Holmes, Cody; Morton, Glenville.
  • Dass B; Eglin Air Force Base Eglin AFB FL USA.
  • Beck A; Eglin Air Force Base Eglin AFB FL USA.
  • Holmes C; Eglin Air Force Base Eglin AFB FL USA.
  • Morton G; Eglin Air Force Base Eglin AFB FL USA.
Clin Case Rep ; 9(1): 395-398, 2021 Jan.
Article in English | MEDLINE | ID: covidwho-938403
ABSTRACT
COVID-19 in the setting of SGLT2 inhibitor use may precipitate euglycemic DKA separate from known acute viral illness and dehydration precipitants. There should be consideration of proactive discontinuation of these medications in these patients.
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Case report Language: English Journal: Clin Case Rep Year: 2021 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Case report Language: English Journal: Clin Case Rep Year: 2021 Document Type: Article